Mode
Text Size
Log in / Sign up

SGLDQR TCM formulas show potential clinical benefits in the management of cholelithiasisTCM Herbs May Ease Gallstones, Review Suggests

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that SGLDQR TCM formulas show potential clinical benefits for cholelithiasis, but evidence certainty is low.

This meta-analysis evaluated the efficacy of SGLDQR TCM formulas, including ZNDST, SGLDQRF, and RPDSJN, in patients with cholelithiasis compared to conventional Western medicine. The analysis included a total sample size of 1,364 patients. The study used SUCRA values to rank the effectiveness of different formulations.

Key findings indicate that the ZNDST formula ranked highest for total effective rate with a SUCRA of 88.2%. The SGLDQRF formula demonstrated potential superiority in TCM syndrome scores with a SUCRA of 85.7%. Additionally, the RPDSJN formula exhibited modulatory effects on liver enzymes, with SUCRA values of 99.9% for serum AST levels and 100.0% for serum ALT levels. Adverse events were reported as mild and self-limiting.

The authors note that the evidence is constrained by the evidence network geometry and study heterogeneity. Furthermore, ranking results and syndrome-differentiation strategies remain exploratory. The study's CINeMA certainty of evidence is rated as low to very low. These findings suggest that SGLDQR TCM formulas may offer comprehensive clinical benefits in the conservative management of cholelithiasis, though the evidence is currently limited in certainty.

How this fits prior evidence

This meta-analysis addresses a gap in the management of cholelithiasis by evaluating TCM formulas. While previous coverage noted that LTAP blocks provide superior early postoperative pain relief compared to port-site infiltration in laparoscopic cholecystectomy, this study focuses on the conservative management of cholelithiasis using SGLDQR TCM formulas. The findings regarding the modulatory effects of RPDSJN on AST and ALT levels provide new data on TCM's role in managing liver enzymes in this patient population.

A new review pooled data from 1,364 people with gallstones to see how certain traditional Chinese medicine formulas compare with standard Western medicine. The formulas included ZNDST, SGLDQRF, and RPDSJN, which contain compounds such as quercetin, wogonin, paeoniflorin, and aloe-emodin.

The review looked at total effective rate, TCM syndrome scores, and blood levels of liver enzymes AST and ALT. ZNDST ranked highest for total effective rate, SGLDQRF showed potential for improving syndrome scores, and RPDSJN appeared to modulate AST and ALT levels. Side effects were reported as mild and self-limiting.

However, the certainty of this evidence was low to very low. The review was limited by the way the studies were connected and by differences among the studies. The rankings and syndrome-based strategies are exploratory, and the idea that anti-inflammatory and metabolic pathways work together is only a hypothesis.

For now, these findings are early and should not change treatment decisions. Anyone with gallstones should talk with their doctor about the best approach for their situation.

What this means for you:
Early evidence suggests some TCM formulas may help gallstones, but certainty is low.

Common questions

Is this treatment safe for gallstones?

The review reported that adverse events were mild and self-limiting. However, serious adverse events and discontinuations were not reported, and the certainty of evidence was low to very low. Talk with your doctor before trying any new treatment.

Who might benefit from these TCM formulas?

The review included 1,364 patients with cholelithiasis. The formulas were compared with conventional Western medicine. Because the evidence is low certainty, it is not clear who would benefit most. A doctor can help assess if this approach is appropriate.

How do these TCM formulas compare with standard treatment?

The review suggested some formulas may be superior to conventional Western medicine for total effective rate and other outcomes. But the rankings are exploratory and the evidence certainty is low to very low. More research is needed before any conclusions can be drawn.

What are the side effects of these herbal formulas?

The review stated that adverse events were mild and self-limiting. No serious adverse events or discontinuations were reported. However, the lack of detailed safety data means you should discuss potential risks with your doctor.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
Although liver-soothing, gallbladder-benefiting, and heat-clearing (SGLDQR) traditional Chinese medicine (TCM) formulas are widely used for cholelithiasis, their systematic efficacy and molecular mechanisms remain poorly understood. This study integrated network meta-analysis (NMA), data mining, network pharmacology, and molecular docking to evaluate the clinical efficacy and clarify the molecular mechanisms of SGLDQR TCM formulas against cholelithiasis. Randomized controlled trials (RCTs) up to December 2024 were retrieved from eight databases. Risk of bias was evaluated using Cochrane RoB 2.0. NMA was conducted using Stata (v14.0) and R (v4.4.3), with treatments ranked by the surface under the cumulative ranking curve (SUCRA) and evidence certainty evaluated via CINeMA. Prescription patterns were mined using the Apriori algorithm. SGLDQR–cholelithiasis common targets were identified across multiple databases, followed by hub target screening using degree centrality and maximal clique centrality (MCC) algorithms and Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) functional enrichment. Finally, blind whole-protein molecular docking of the top three hub targets with active ingredients was performed using AutoDock Vina (v1.1.2) and verified via PLIP. Thirteen RCTs involving 1,364 patients and 12 SGLDQR formulas were included. NMA revealed that herbal formulas outperformed conventional Western medicine. Self-prepared Danshi Decoction (ZNDST) ranked highest in improving total effective rate (SUCRA: 88.2%), the Shugan Lidan Qingre formula (SGLDQRF) demonstrated potential superiority in improving TCM syndrome scores (SUCRA: 85.7%), and Rongpai Danshi Capsules (RPDSJN) exhibited a modulatory effect in reducing serum AST (99.9%) and ALT (100.0%) levels. Adverse events were mild and self-limiting. CINeMA certainty of evidence was low to very low. Data mining indicated that these formulas were predominantly cold in nature, combined bitter, pungent, and sweet flavors, and mainly targeted the spleen, liver, and stomach meridians, focusing on clearing heat, draining dampness, soothing the liver, and promoting gallbladder function, driven by 8 core herbs. Network pharmacology identified active compounds such as quercetin, wogonin, paeoniflorin, and aloe-emodin, which acted on key targets including IL-6, IL-1β, and TNF-α, primarily enriched in inflammatory cascades and lipid-metabolism pathways. Molecular docking predicted favorable binding affinities between the key active compounds and core targets. SGLDQR TCM formulas demonstrate potential comprehensive clinical benefits in the conservative management of cholelithiasis. However, constrained by the evidence network geometry and study heterogeneity, the ranking results and syndrome-differentiation strategies remain exploratory. The predicted synergism between anti-inflammatory and metabolic pathways provides a mechanistic hypothesis for subsequent research. Future rigorous multicenter, double-blind RCTs along with in vitro and in vivo functional assays are warranted for validation. https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42024598181.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.